SlideShare a Scribd company logo
1 of 4
Download to read offline
GABRIEL MUÑIZ
Miami, FL
LinkedIn Profile
EXPERIENCE
10/2015 – PRESENT
SUPERVISORY CONSUMER SAFETY OFFICER, U.S. FOOD AND DRUG
ADMINISTRATION
As the first-ever supervisor of FDA’s Office of Regulatory Affairs (ORA), Tobacco Operations Staff
(TOS), I am responsible for collaborating with the Center for Tobacco Products (CTP) on
compliance and enforcement activities for the tobacco program and to implement policies
relating to the Federal Food, Drug, and Cosmetic Act and the Family Smoking Prevention and
Tobacco Control Act to regulate the manufacture, distribution and marketing of tobacco
products. In this capacity, I am responsible for the strategic development of the tobacco
program and for operational oversight of staff responsible for conducting inspections,
investigations, and compliance activities.
My accomplishments and impacts include:
Strategic development of the tobacco program:
• Apply tobacco program expertise and fully participate in all phases of strategic program
planning with ORA senior leadership to develop and implement the tobacco program
policies and objectives, short and long-term goals, and operating policies to achieve the
mission of the Agency to protect the public. For example: development and execution
of the tobacco program work plans for FYs 2016 to present, Tobacco Field Committees
for FYs 2016 to present, and inspection and investigation assignments.
• Collaborate with ORA’s Office of Management to formulate, monitor, and support the
tobacco program budget. I am responsible for the execution of a multi-million tobacco
program budget.
• In collaboration with CTP and ORA senior leadership, I contribute to the development of
the position descriptions, recruitment, and selection of an interdisciplinary tobacco
operations staff. Since 2015, I have supported the growth of the tobacco operations
staff from 5 FTE’s to the current staff of 15, consisting of 12 investigators, 1 compliance
officer, 1 program support assistant, and 1 supervisor.
• Apply my subject matter expertise of the tobacco program to review and analyze
proposed tobacco product regulations and policies to ensure that they are consistent
with the strategic goals and objectives of the tobacco program and consistent with ORA
policies and practices, for example, the deeming regulation, the proposed tobacco
product manufacturing practice regulation, the proposed administrative detention
regulation.
Operational oversight of the tobacco program:
2
• I am responsible for conducting periodic review of the progress and accomplishments of
the tobacco program and provide reports to ORA senior leadership. The
accomplishments of the tobacco program include:
- FY2016: Successfully completed 102% of the workplan obligations for inspections;
140% of the workplan obligations for investigations.
- FY2017: Successfully completed 104% of the workplan obligations for inspections;
143% of the workplan obligations for investigations.
- FY2018: Successfully completed 136% of the workplan obligations for inspections;
100% of the workplan obligations for investigations.
• Monitor the progress of the tobacco program in terms of resource allocation and funding
requirements.
• Continuously manage and direct the field activities of 14 Tobacco Operations Staff,
consisting of 12 investigators, 1 compliance officer, 1 program support assistant. This
includes managing all employee resources issues, i.e., equal opportunity, ensuring a safe
and healthy work environment, assigning work, reviewing and approving/rejecting work
products, approving leave, establishing training to ensure that technical competence is
maintained and promote employee career development, directing actions to correct
performance deficiencies, conducting and approving performance appraisals, and
initiating and approving performance awards.
• Reviewing and approving classifications of all work products and proposed enforcement
actions to protect the public health. The enforcement accomplishments of the tobacco
program include:
- Multiple Official Action Indicated (OAI) classifications, resulting in over a dozen
Warning Letters, all of which are the first-of-its-kind actions.
- Multiple recalls and emergency response activities have been completed since
FY2016.
- Multiple consumer complaints have been successfully investigated since FY2016.
The position reports directly to the Assistant Commissioner for Medical Products and Tobacco
Operations.
04/2015 – 6/2015
CONSUMER SAFETY OFFICER (TEAM LEAD - TOBACCO CADRE), U.S. FOOD AND
DRUG ADMINISTRATION
Lead investigator who acts in the capacity of a first line supervisor for the Tobacco Cadre
investigators.
The incumbent is considered the top program expert and has:
• Mastered the principles, practices, and theories utilized in the production of tobacco products
(equipment, manufacturing, processing, control and testing methodology) to serve as a technical
authority in processes, analysis, behavior, risks and the impact of the processes of the tobacco
products; provide authoritative advice and assistance on extensive, complex, and complicated
manufacturing processes and operations, and inspectional problems relative to the tobacco
products; recognize any discrepancies or inconsistencies between information reported and
made available and the true nature of the manufacturer being inspected or investigated; and,
3
provide written analyses of data and in-depth fault analysis evaluations and product failures
aimed at preserving and protecting the public health.
• Broad knowledge of a variety of various scientific and technical disciplines to carry out tasks
related to the regulation of the tobacco industry and related test instrumentation.
• Knowledge of written and verbal communication practices and principles to prepare and
present written reports, findings, and recommendations~ develop analyses that are used for
presentations and as instruments for negotiation; conduct negotiations with industry
representatives and other government agencies; and, develop formal training programs.
• Comprehensive knowledge of the Food, Drug, and Cosmetic Act, PHS Act, The Family Smoking
Prevention and Tobacco Control Act and other implementing rules and regulations, licensing
processes and court precedents which apply to the area of assigned responsibility. Skill to
interpret these laws, policies, etc., and their application to the broad field of tobacco products.
The position reports directly to the Director in the Office of Medical Products and Tobacco
Operations.
05/2014 – 10/2015
CONSUMER SAFETY OFFICER (TOBACCO CADRE), U.S. FOOD AND DRUG
ADMINISTRATION
This position represents an expert level within ORA for the inspection and investigation of
Tobacco products, firms and facilities sufficient for the incumbent to assume primary
responsibility for carrying out inspectional or investigational assignments in the Tobacco Cadre.
Assignments are of such complexity to require the incumbent to possess comprehensive
knowledge of the science related to the Tobacco products functional area, as well as an intimate
knowledge of industry practices which have been acquired by extensive, complex technical
training and/or experience in investigations and inspections.
Specifically the incumbent: serves as a technical expert in inspectional and investigative
techniques in the specialized functional area of Tobacco products with responsibility for
conducting comprehensive foreign or domestic Inspections and investigations of FDA regulated
Tobacco industry firms and manufacturing facilities, foreign and domestic, as well as for
providing expert advice to ORA management, the CTP and other ORA specialists nationwide;
conducts special complex studies; inspections and investigations, such as possible adulteration,
misbranding or illicit trade of Tobacco products; participates in developing and conducting,
within the tobacco program area, specialized, highly technical and complex training courses to
investigators selected on a nationwide basis, including investigators and personnel from various
state and foreign governments and regulated industry; is consulted in matters pertaining to the
promulgating of regulations and reviews and comments on the feasibility or desirability of draft
proposals; participates in the formulation and development of inspectional and investigational
procedures and techniques pertaining to problems within the functional program area.
The position reports directly to the Deputy Director in the Office of Medical Products and
Tobacco Operations.
01/2009 – 5/2014
4
CONSUMER SAFETY OFFICER (GENERALIST), U.S. FOOD AND DRUG
ADMINISTRATION
Concentration: Biologics, Food (Seafood HACCP Level II Certified / Interstate Travel Program (ITP)
Investigator), Medical Device, Bioresearch Monitoring (BIMO), Emergency Response (Florida
Planning Section Chief), and Florida State Inspector Auditor (FDACS).
Duties:
Investigating complaints of injury, illness, or death caused by a product regulated by the FDA;
Initiating actions against violators; advising and training industry, State and local officials and
consumers on enforcement policies, methods, and interpretation of regulations and their impact
on public health; Developing, drafting and coordinating clearance and issuance of Federal
Register rules and notices, as well as citizen petition responses; policy guidance; Applying the
Freedom of Information Act (FOIA) and the Food, Drug and Cosmetic Act(FD&C) to a variety of
requests for information concerning FDA's scientific/regulatory activities; and other consultations
concerning regulatory matters; Plan and direct regulatory programs and/or develop inspections
of regulated industry, or manage and coordinate the review process of marketing applications.
The position reports directly to a first line supervisor at the Miami Resident Post within the
Florida District Office.
EDUCATION
APRIL 2007
BACHELOR OF SCIENCE – HEALTH SCIENCE, FLORIDA INTERNATIONAL UNIVERSITY
FDA AWARDS
• May 2019 - Group Recognition Award - For
outstanding teamwork in coordinating a
precedent-setting warning letter preventing the
illegal manufacture and sale of unapproved new
tobacco products resembling kid-friendly foods.
• August 2016 - Group Recognition Award - For
developing complex scientific evaluation and
communication plans to support the first FDA
pre-market tobacco application (PMTA)
marketing authorization.
• June 2011 - Group Recognition Award - For
exceptional coordination, cooperation and
performance during three medical device QSIT
inspections that resulted in a Mass Seizure of
dental medical devices.
• June 2017 - Commissioner's Special Citation
- For demonstrating scientific expertise,
teamwork, and innovation in the review of
Modified Risk Tobacco Products
Applications.
• July 2013 - Group Recognition Award - For
exemplary planning and execution of the
food safety mission for the Republican and
Democratic National Conventions through
the successful integration of local, state and
federal resources.
SKILLS
Knowledge in eNSpect, OSAR, FACTS, FURLS (TRLM), ORADSS, OASIS, MARCS-CMS, QMiS, ECMS, iTRAC,
CTP Business Objects, GIS / GeoWeb, TOS Dashboard, ITAS, eCORPS, Concur (CGE), Sharepoint, Minitab
15 Statistical Software, TE Acceptance Sampling Programs, Test Sample Normality Software, etc.

More Related Content

What's hot

Presentation: CMA Advertising Seminar
Presentation: CMA Advertising SeminarPresentation: CMA Advertising Seminar
Presentation: CMA Advertising SeminarTGA Australia
 
Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsTGA Australia
 
Journal of Pharmaceutical Regulatory Affairs
Journal of Pharmaceutical Regulatory AffairsJournal of Pharmaceutical Regulatory Affairs
Journal of Pharmaceutical Regulatory AffairsOMICS International
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...TGA Australia
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...TGA Australia
 
TGOs versus Pharmacopoeias: Do I have a choice?
TGOs versus Pharmacopoeias: Do I have a choice?TGOs versus Pharmacopoeias: Do I have a choice?
TGOs versus Pharmacopoeias: Do I have a choice?TGA Australia
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesTGA Australia
 
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...TGA Australia
 
Presentation: The Australian Pharmacovigilance Inspection Program (PVIP)
Presentation: The Australian Pharmacovigilance Inspection Program (PVIP)Presentation: The Australian Pharmacovigilance Inspection Program (PVIP)
Presentation: The Australian Pharmacovigilance Inspection Program (PVIP)TGA Australia
 

What's hot (10)

NATIONAL DRUG REPORT
NATIONAL DRUG REPORTNATIONAL DRUG REPORT
NATIONAL DRUG REPORT
 
Presentation: CMA Advertising Seminar
Presentation: CMA Advertising SeminarPresentation: CMA Advertising Seminar
Presentation: CMA Advertising Seminar
 
Pharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirementsPharmacovigilance and complementary medicines - Regulatory requirements
Pharmacovigilance and complementary medicines - Regulatory requirements
 
Journal of Pharmaceutical Regulatory Affairs
Journal of Pharmaceutical Regulatory AffairsJournal of Pharmaceutical Regulatory Affairs
Journal of Pharmaceutical Regulatory Affairs
 
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
 
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
 
TGOs versus Pharmacopoeias: Do I have a choice?
TGOs versus Pharmacopoeias: Do I have a choice?TGOs versus Pharmacopoeias: Do I have a choice?
TGOs versus Pharmacopoeias: Do I have a choice?
 
Updates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changesUpdates to Good Manufacturing Practices - Recent, current and future changes
Updates to Good Manufacturing Practices - Recent, current and future changes
 
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...
Presentation Therapeutic Goods (Standard for Tablets, Capsules and Pills) (TG...
 
Presentation: The Australian Pharmacovigilance Inspection Program (PVIP)
Presentation: The Australian Pharmacovigilance Inspection Program (PVIP)Presentation: The Australian Pharmacovigilance Inspection Program (PVIP)
Presentation: The Australian Pharmacovigilance Inspection Program (PVIP)
 

Similar to Gabriel Muniz FDA Only Resume

KASSI SOCIAL MEDIA ENTRY LEVEL MANAGEMENT
KASSI SOCIAL MEDIA ENTRY LEVEL MANAGEMENT KASSI SOCIAL MEDIA ENTRY LEVEL MANAGEMENT
KASSI SOCIAL MEDIA ENTRY LEVEL MANAGEMENT Kassi Ogles
 
Sr medical writer cover letter
Sr medical writer cover letterSr medical writer cover letter
Sr medical writer cover letterIan Vallejo
 
Nick lawrence cv 2015 v1
Nick lawrence cv 2015 v1Nick lawrence cv 2015 v1
Nick lawrence cv 2015 v1Nick Lawrence
 
1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptx1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptxMdJubair13
 
Nick Lawrence CV 2016 v2
Nick Lawrence CV 2016 v2Nick Lawrence CV 2016 v2
Nick Lawrence CV 2016 v2Nick Lawrence
 
Jacqueline Flounders CV September 2016
Jacqueline Flounders CV September 2016Jacqueline Flounders CV September 2016
Jacqueline Flounders CV September 2016jacqui flounders
 
Good Governance for Medicines in Jordan
Good Governance for Medicines in JordanGood Governance for Medicines in Jordan
Good Governance for Medicines in JordanMeTApresents
 
Regulatory affairs by sachin gundecha
Regulatory affairs by sachin gundechaRegulatory affairs by sachin gundecha
Regulatory affairs by sachin gundechaSachin Gundecha
 
Creating a Comprehensive Drug Development Plan
Creating a Comprehensive Drug Development PlanCreating a Comprehensive Drug Development Plan
Creating a Comprehensive Drug Development PlanCovance
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014Dinesh T
 
Draft Policy on Quality System as an Integrated Policy
Draft Policy on Quality System as an Integrated PolicyDraft Policy on Quality System as an Integrated Policy
Draft Policy on Quality System as an Integrated PolicyObaid Ali / Roohi B. Obaid
 
Amit_Kumar_15052015_AG
Amit_Kumar_15052015_AGAmit_Kumar_15052015_AG
Amit_Kumar_15052015_AGAmit Kumar
 

Similar to Gabriel Muniz FDA Only Resume (20)

KASSI SOCIAL MEDIA ENTRY LEVEL MANAGEMENT
KASSI SOCIAL MEDIA ENTRY LEVEL MANAGEMENT KASSI SOCIAL MEDIA ENTRY LEVEL MANAGEMENT
KASSI SOCIAL MEDIA ENTRY LEVEL MANAGEMENT
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
Drugs & Alcohol in the Workplace Guide for Managers
Drugs & Alcohol in the Workplace Guide for ManagersDrugs & Alcohol in the Workplace Guide for Managers
Drugs & Alcohol in the Workplace Guide for Managers
 
MPOWER Brochure
MPOWER BrochureMPOWER Brochure
MPOWER Brochure
 
Sr medical writer cover letter
Sr medical writer cover letterSr medical writer cover letter
Sr medical writer cover letter
 
Nick lawrence cv 2015 v1
Nick lawrence cv 2015 v1Nick lawrence cv 2015 v1
Nick lawrence cv 2015 v1
 
1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptx1. Introduction to regulatory affairs (2).pptx
1. Introduction to regulatory affairs (2).pptx
 
Nick Lawrence CV 2016 v2
Nick Lawrence CV 2016 v2Nick Lawrence CV 2016 v2
Nick Lawrence CV 2016 v2
 
Jacqueline Flounders CV September 2016
Jacqueline Flounders CV September 2016Jacqueline Flounders CV September 2016
Jacqueline Flounders CV September 2016
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
Layfield-Christopher-BHR-Baltimore-2014
Layfield-Christopher-BHR-Baltimore-2014Layfield-Christopher-BHR-Baltimore-2014
Layfield-Christopher-BHR-Baltimore-2014
 
Good Governance for Medicines in Jordan
Good Governance for Medicines in JordanGood Governance for Medicines in Jordan
Good Governance for Medicines in Jordan
 
MS_Reg Sci One Page Flyer 2014-2015
MS_Reg Sci One Page Flyer 2014-2015MS_Reg Sci One Page Flyer 2014-2015
MS_Reg Sci One Page Flyer 2014-2015
 
CV_ Martha Alicia Garcia Limon_LNK
CV_ Martha Alicia Garcia Limon_LNKCV_ Martha Alicia Garcia Limon_LNK
CV_ Martha Alicia Garcia Limon_LNK
 
Regulatory affairs by sachin gundecha
Regulatory affairs by sachin gundechaRegulatory affairs by sachin gundecha
Regulatory affairs by sachin gundecha
 
Creating a Comprehensive Drug Development Plan
Creating a Comprehensive Drug Development PlanCreating a Comprehensive Drug Development Plan
Creating a Comprehensive Drug Development Plan
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
Proposed Supplier Qualification Policy
Proposed Supplier Qualification PolicyProposed Supplier Qualification Policy
Proposed Supplier Qualification Policy
 
Draft Policy on Quality System as an Integrated Policy
Draft Policy on Quality System as an Integrated PolicyDraft Policy on Quality System as an Integrated Policy
Draft Policy on Quality System as an Integrated Policy
 
Amit_Kumar_15052015_AG
Amit_Kumar_15052015_AGAmit_Kumar_15052015_AG
Amit_Kumar_15052015_AG
 

Gabriel Muniz FDA Only Resume

  • 1. GABRIEL MUÑIZ Miami, FL LinkedIn Profile EXPERIENCE 10/2015 – PRESENT SUPERVISORY CONSUMER SAFETY OFFICER, U.S. FOOD AND DRUG ADMINISTRATION As the first-ever supervisor of FDA’s Office of Regulatory Affairs (ORA), Tobacco Operations Staff (TOS), I am responsible for collaborating with the Center for Tobacco Products (CTP) on compliance and enforcement activities for the tobacco program and to implement policies relating to the Federal Food, Drug, and Cosmetic Act and the Family Smoking Prevention and Tobacco Control Act to regulate the manufacture, distribution and marketing of tobacco products. In this capacity, I am responsible for the strategic development of the tobacco program and for operational oversight of staff responsible for conducting inspections, investigations, and compliance activities. My accomplishments and impacts include: Strategic development of the tobacco program: • Apply tobacco program expertise and fully participate in all phases of strategic program planning with ORA senior leadership to develop and implement the tobacco program policies and objectives, short and long-term goals, and operating policies to achieve the mission of the Agency to protect the public. For example: development and execution of the tobacco program work plans for FYs 2016 to present, Tobacco Field Committees for FYs 2016 to present, and inspection and investigation assignments. • Collaborate with ORA’s Office of Management to formulate, monitor, and support the tobacco program budget. I am responsible for the execution of a multi-million tobacco program budget. • In collaboration with CTP and ORA senior leadership, I contribute to the development of the position descriptions, recruitment, and selection of an interdisciplinary tobacco operations staff. Since 2015, I have supported the growth of the tobacco operations staff from 5 FTE’s to the current staff of 15, consisting of 12 investigators, 1 compliance officer, 1 program support assistant, and 1 supervisor. • Apply my subject matter expertise of the tobacco program to review and analyze proposed tobacco product regulations and policies to ensure that they are consistent with the strategic goals and objectives of the tobacco program and consistent with ORA policies and practices, for example, the deeming regulation, the proposed tobacco product manufacturing practice regulation, the proposed administrative detention regulation. Operational oversight of the tobacco program:
  • 2. 2 • I am responsible for conducting periodic review of the progress and accomplishments of the tobacco program and provide reports to ORA senior leadership. The accomplishments of the tobacco program include: - FY2016: Successfully completed 102% of the workplan obligations for inspections; 140% of the workplan obligations for investigations. - FY2017: Successfully completed 104% of the workplan obligations for inspections; 143% of the workplan obligations for investigations. - FY2018: Successfully completed 136% of the workplan obligations for inspections; 100% of the workplan obligations for investigations. • Monitor the progress of the tobacco program in terms of resource allocation and funding requirements. • Continuously manage and direct the field activities of 14 Tobacco Operations Staff, consisting of 12 investigators, 1 compliance officer, 1 program support assistant. This includes managing all employee resources issues, i.e., equal opportunity, ensuring a safe and healthy work environment, assigning work, reviewing and approving/rejecting work products, approving leave, establishing training to ensure that technical competence is maintained and promote employee career development, directing actions to correct performance deficiencies, conducting and approving performance appraisals, and initiating and approving performance awards. • Reviewing and approving classifications of all work products and proposed enforcement actions to protect the public health. The enforcement accomplishments of the tobacco program include: - Multiple Official Action Indicated (OAI) classifications, resulting in over a dozen Warning Letters, all of which are the first-of-its-kind actions. - Multiple recalls and emergency response activities have been completed since FY2016. - Multiple consumer complaints have been successfully investigated since FY2016. The position reports directly to the Assistant Commissioner for Medical Products and Tobacco Operations. 04/2015 – 6/2015 CONSUMER SAFETY OFFICER (TEAM LEAD - TOBACCO CADRE), U.S. FOOD AND DRUG ADMINISTRATION Lead investigator who acts in the capacity of a first line supervisor for the Tobacco Cadre investigators. The incumbent is considered the top program expert and has: • Mastered the principles, practices, and theories utilized in the production of tobacco products (equipment, manufacturing, processing, control and testing methodology) to serve as a technical authority in processes, analysis, behavior, risks and the impact of the processes of the tobacco products; provide authoritative advice and assistance on extensive, complex, and complicated manufacturing processes and operations, and inspectional problems relative to the tobacco products; recognize any discrepancies or inconsistencies between information reported and made available and the true nature of the manufacturer being inspected or investigated; and,
  • 3. 3 provide written analyses of data and in-depth fault analysis evaluations and product failures aimed at preserving and protecting the public health. • Broad knowledge of a variety of various scientific and technical disciplines to carry out tasks related to the regulation of the tobacco industry and related test instrumentation. • Knowledge of written and verbal communication practices and principles to prepare and present written reports, findings, and recommendations~ develop analyses that are used for presentations and as instruments for negotiation; conduct negotiations with industry representatives and other government agencies; and, develop formal training programs. • Comprehensive knowledge of the Food, Drug, and Cosmetic Act, PHS Act, The Family Smoking Prevention and Tobacco Control Act and other implementing rules and regulations, licensing processes and court precedents which apply to the area of assigned responsibility. Skill to interpret these laws, policies, etc., and their application to the broad field of tobacco products. The position reports directly to the Director in the Office of Medical Products and Tobacco Operations. 05/2014 – 10/2015 CONSUMER SAFETY OFFICER (TOBACCO CADRE), U.S. FOOD AND DRUG ADMINISTRATION This position represents an expert level within ORA for the inspection and investigation of Tobacco products, firms and facilities sufficient for the incumbent to assume primary responsibility for carrying out inspectional or investigational assignments in the Tobacco Cadre. Assignments are of such complexity to require the incumbent to possess comprehensive knowledge of the science related to the Tobacco products functional area, as well as an intimate knowledge of industry practices which have been acquired by extensive, complex technical training and/or experience in investigations and inspections. Specifically the incumbent: serves as a technical expert in inspectional and investigative techniques in the specialized functional area of Tobacco products with responsibility for conducting comprehensive foreign or domestic Inspections and investigations of FDA regulated Tobacco industry firms and manufacturing facilities, foreign and domestic, as well as for providing expert advice to ORA management, the CTP and other ORA specialists nationwide; conducts special complex studies; inspections and investigations, such as possible adulteration, misbranding or illicit trade of Tobacco products; participates in developing and conducting, within the tobacco program area, specialized, highly technical and complex training courses to investigators selected on a nationwide basis, including investigators and personnel from various state and foreign governments and regulated industry; is consulted in matters pertaining to the promulgating of regulations and reviews and comments on the feasibility or desirability of draft proposals; participates in the formulation and development of inspectional and investigational procedures and techniques pertaining to problems within the functional program area. The position reports directly to the Deputy Director in the Office of Medical Products and Tobacco Operations. 01/2009 – 5/2014
  • 4. 4 CONSUMER SAFETY OFFICER (GENERALIST), U.S. FOOD AND DRUG ADMINISTRATION Concentration: Biologics, Food (Seafood HACCP Level II Certified / Interstate Travel Program (ITP) Investigator), Medical Device, Bioresearch Monitoring (BIMO), Emergency Response (Florida Planning Section Chief), and Florida State Inspector Auditor (FDACS). Duties: Investigating complaints of injury, illness, or death caused by a product regulated by the FDA; Initiating actions against violators; advising and training industry, State and local officials and consumers on enforcement policies, methods, and interpretation of regulations and their impact on public health; Developing, drafting and coordinating clearance and issuance of Federal Register rules and notices, as well as citizen petition responses; policy guidance; Applying the Freedom of Information Act (FOIA) and the Food, Drug and Cosmetic Act(FD&C) to a variety of requests for information concerning FDA's scientific/regulatory activities; and other consultations concerning regulatory matters; Plan and direct regulatory programs and/or develop inspections of regulated industry, or manage and coordinate the review process of marketing applications. The position reports directly to a first line supervisor at the Miami Resident Post within the Florida District Office. EDUCATION APRIL 2007 BACHELOR OF SCIENCE – HEALTH SCIENCE, FLORIDA INTERNATIONAL UNIVERSITY FDA AWARDS • May 2019 - Group Recognition Award - For outstanding teamwork in coordinating a precedent-setting warning letter preventing the illegal manufacture and sale of unapproved new tobacco products resembling kid-friendly foods. • August 2016 - Group Recognition Award - For developing complex scientific evaluation and communication plans to support the first FDA pre-market tobacco application (PMTA) marketing authorization. • June 2011 - Group Recognition Award - For exceptional coordination, cooperation and performance during three medical device QSIT inspections that resulted in a Mass Seizure of dental medical devices. • June 2017 - Commissioner's Special Citation - For demonstrating scientific expertise, teamwork, and innovation in the review of Modified Risk Tobacco Products Applications. • July 2013 - Group Recognition Award - For exemplary planning and execution of the food safety mission for the Republican and Democratic National Conventions through the successful integration of local, state and federal resources. SKILLS Knowledge in eNSpect, OSAR, FACTS, FURLS (TRLM), ORADSS, OASIS, MARCS-CMS, QMiS, ECMS, iTRAC, CTP Business Objects, GIS / GeoWeb, TOS Dashboard, ITAS, eCORPS, Concur (CGE), Sharepoint, Minitab 15 Statistical Software, TE Acceptance Sampling Programs, Test Sample Normality Software, etc.